BioMarin Pharmaceutical Inc. buy Barclays PLC
Start price
06.08.24
/
50%
€79.46
Target price
06.08.25
€100.74
Performance (%)
-34.76%
End price
07.08.25
€51.84
Summary
This prediction ended on 07.08.25 with a price of €51.84. The BUY prediction by Barclays_PLC for BioMarin Pharmaceutical Inc. performed very badly with a performance of -34.76%. Barclays_PLC has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.635% | 5.635% | -18.419% |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% |
Comments by Barclays_PLC for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Barclays PLC from $111.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€68.62
28.10.26
28.10.26
13.52%
23.02.26
23.02.26
Stopped prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€47.65
28.01.26
28.01.26
€66.71
28.01.27
28.01.27
11.73%
23.02.26
23.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
04.10.24
04.10.24
€78.35
04.10.25
04.10.25
-24.70%
05.10.25
05.10.25